Presentation is loading. Please wait.

Presentation is loading. Please wait.

The impact of obesity on drug prescribing in primary care BJGP Volume 55(519):743-749 October 1, 2005 ©2005 by British Journal of General Practice.

Similar presentations


Presentation on theme: "The impact of obesity on drug prescribing in primary care BJGP Volume 55(519):743-749 October 1, 2005 ©2005 by British Journal of General Practice."— Presentation transcript:

1 The impact of obesity on drug prescribing in primary care BJGP Volume 55(519):743-749 October 1, 2005 ©2005 by British Journal of General Practice

2 Prevalence of polypharmacy defined as >4 drugs during an 18-month period by body mass index status and age group. Counterweight Project Team Br J Gen Pract 2005;55:743- 749 ©2005 by British Journal of General Practice

3 Prevalence of polypharmacy defined as >4 drugs during an 18-month period by body mass index status and number of comorbidities (see Supplementary Appendix 3). Counterweight Project Team Br J Gen Pract 2005;55:743- 749 ©2005 by British Journal of General Practice


Download ppt "The impact of obesity on drug prescribing in primary care BJGP Volume 55(519):743-749 October 1, 2005 ©2005 by British Journal of General Practice."

Similar presentations


Ads by Google